Episurf Medical AB (publ) (EPIS-B.ST) Research

Episurf Medical AB (publ) is a Swedish medical technology company that specializes in the development and production of orthopedic implants and surgical instruments. Its innovative solutions are distributed across the Nordic countries, Germany, the United Kingdom, and various international markets. The company offers a range of Episealer implants designed to address localized cartilage and underlying bone defects. These include the Episealer Condyle Solo, specifically for the femoral condyles of the knee joint; the Episealer Trochlea Solo, targeting defects located behind the patella; and the Episealer Femoral Twin, which is used for more extensive, elongated defects found on the femoral condyles and within the trochlea area of the knee. For the ankle, Episurf provides the Episealer Talus, intended for osteochondral lesions of the talar dome. Beyond implants, their product line features surgical drill guides such as Epiguide, and the Epiguide MOS, specifically engineered for mosaicplasty procedures to treat deep cartilage and bone defects in the knee. Episurf also provides µiFidelity, a proprietary order management system. This platform facilitates order placement and tracking, allows for MRI scan uploads, and enables consultation of patient damage marking reports. Established in 2008 and headquartered in Stockholm, Sweden, the company adopted its current name, Episurf Medical AB (publ), in 2010, having previously operated as Diamorph Medtech AB.

Open Episurf Medical AB (publ) (EPIS-B.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.